Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 30, 2025	Mar. 31, 2024
Net sales	$ 153,044	$ 158,636
Cost of goods sold	88,956	106,577
Gross profit	64,088	52,059
Selling, general, and administrative	36,699	32,996
Research and development costs	4,093	4,812
Amortization of intangible assets	3,532	3,436
Restructuring costs	463	615
Other operating income	(42)	(8)
Total operating expense	44,745	41,851
Operating income	19,343	10,208
Fair value adjustments to warrant liability	(73)	(3,127)
Fair value adjustments to earn-out liability	(185)	(649)
Loss on early extinguishment of long-term debt	0	141
Interest expense, net	(15,708)	(11,004)
Total non-operating expense	15,450	7,369
Income before income taxes	3,893	2,839
Income tax expense (benefit)	1,076	(891)
Net income	2,817	3,730
Comprehensive income (loss):
Foreign currency translation adjustment	(285)	(186)
Total comprehensive income	$ 2,532	$ 3,544
Common Share Data:
Weighted average common shares outstanding - basic (in shares)	118,845,487	117,871,829
Weighted average common shares outstanding - diluted (in shares)	119,559,217	119,505,330
Basic net income per share (in dollars per share)	$ 0.02	$ 0.03
Diluted net income per share (in dollars per share)	$ 0.02	$ 0.03